Casdin Capital Amends Stake in Standard BioTools

TL;DR

Casdin Capital just updated their 13D for Standard BioTools. Big player making moves.

AI Summary

Casdin Capital, LLC, through its filing on August 14, 2024, has amended its Schedule 13D regarding Standard BioTools Inc. The filing indicates a change in beneficial ownership, with Casdin Capital, LLC now holding a significant stake in the company's common stock. This amendment reflects updated information on their holdings and intentions concerning Standard BioTools Inc.

Why It Matters

This filing signals a potential shift in control or influence for Standard BioTools Inc., as a significant investment firm updates its position. Investors will monitor Casdin Capital's future actions for insights into the company's prospects.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant investor activity, which can lead to volatility and potential changes in company strategy.

Key Players & Entities

• Casdin Capital, LLC (company) — Filing entity
• Standard BioTools Inc. (company) — Subject company
• Eli Casdin (person) — Authorized to receive notices

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
• $78,750,000 — F in exchange for cash consideration of $78,750,000 and (b) 33,750 shares of Series B-1 Pre
• $33,750,000 — I in exchange for cash consideration of $33,750,000. Pursuant to the Loan Agreement (define
• $8,750,000 — aggregate original principal amount of $8,750,000 and (ii) Casdin PGEII provided a term l
• $3,750,000 — aggregate original principal amount of $3,750,000. Upon the issuance of the Series B-1 Pr
• $0.0001 — of common stock of SomaLogic, par value $0.0001 per share (“SomaLogic Common Stoc
• $1.6319 — Casdin PMF Common Stock 1,000,000 $1.6319 (1) 8/5/2024 Casdin PMF Common Stoc
• $1.5839 — 24 Casdin PMF Common Stock 200,000 $1.5839 (2) 8/7/2024 Casdin PMF Common Stoc
• $1.5724 — 24 Casdin PMF Common Stock 500,000 $1.5724 (3) 8/8/2024 Casdin PMF Common Stoc
• $1.6374 — 24 Casdin PMF Common Stock 569,562 $1.6374 (4) 8/9/2024 Casdin PMF Common Stoc
• $1.6149 — 24 Casdin PMF Common Stock 525,408 $1.6149 (5) 8/12/2024 Casdin PMF Common Sto
• $1.6412 — 24 Casdin PMF Common Stock 500,000 $1.6412 (6) 8/13/2024 Casdin PMF Common Sto
• $1.6192 — 24 Casdin PMF Common Stock 550,000 $1.6192 (7) 8/14/2024 Casdin PMF Common Sto
• $1.5946 — Casdin PMF Common Stock 1,200,000 $1.5946 (8) (1) The price reported is a weigh
• $1.5462 — ltiple transactions within the range of $1.5462 to $1.6583. The Reporting Persons under

Filing Documents

• d11444578_13d-a.htm (SC 13D/A) — 172KB
• 0000919574-24-004765.txt ( ) — 174KB

From the Filing

SC 13D/A 1 d11444578_13d-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* Standard BioTools Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 34385P108 (CUSIP Number) Eli Casdin Casdin Capital, LLC 1350 Avenue of the Americas, Suite 2600 New York, New York 10019 (212) 897-5430 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 12, 2024 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. _____________ * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. CUSIP No. 34385P108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Casdin Capital, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] 3. SEC USE ONLY 4. SOURCE OF FUNDS AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON 7. SOLE VOTING POWER 0 8. SHARED VOTING POWER 69,004,677 9. SOLE DISPOSITIVE POWER 0 10. SHARED DISPOSITIVE POWER 69,004,677 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 69,004,677 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [_] 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 18.59% 14. TYPE OF REPORTING PERSON IA CUSIP No. 34385P108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Casdin Private Growth Equity Fund II, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] 3. SEC USE ONLY 4. SOURCE OF FUNDS WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON 7. SOLE VOTING POWER 0 8. SHARED VOTING POWER 13,939,637 9. SOLE DISPOSITIVE POWER 0 10. SHARED DISPOSITIVE POWER 13,939,637 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 13,939,637 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [_] 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.76% 14. TYPE OF REPORTING PERSON PN CUSIP No. 34385P108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Casdin Private Growth Equity Fund II GP, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] 3. SEC USE ONLY 4. SOURCE OF FUNDS AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON 7. SOLE VOTING POWER 0 8. SHARED VOTING POWER 13,939,637 9. SOLE DISPOSITIVE POWER 0 10. SHARED DISPOSITIVE POWER 13,939,637 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 13,939,637 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [_] 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.76% 14. TYPE OF REPORTING PERSON OO CUSIP No. 34385P108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Casdin Partners Master Fund, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] 3. SEC USE ONLY 4. SOURCE OF FUNDS WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] 6. CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON 7. SOLE VOTING POWER 0 8. SHARED VOTING POWER 51,775,821 9. SOLE DISPOSITIVE POWER 0 10. SHARED DISPOSITIVE POWER 51,775,821 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 51,775,821 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [_] 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13.95% 14. TYPE OF REPORTING PERSON PN CUSIP No. 34385P108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Casdin Partners GP, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_

View Full Filing

View this SC 13D/A filing on SEC EDGAR